MIGRA THERAPEUTICS
Migra Therapeutics is developing nanotechnology therapies for cancer. Some types of cancer, particularly pancreatic cancer and breast cancer, are comprised of dense barrier cells called “stroma,” which resist penetration by drug therapy. Migra Therapeutics has engineered a protein that targets a receptor in these cancer cells; the protein binds to the cancer cells to deliver therapies more effectively. Migra’s system can be used to deliver chemotherapy drugs, therapeutic antibodies and most importantly, nanoparticle drugs. Early testing of the company’s targeted drug delivery system has shown promising results for treating pancreatic and breast cancer. More testing is needed, but the company aims to fundamentally change the future of nanotechnology cancer treatment.
MIGRA THERAPEUTICS
Industry:
Biotechnology Life Science Therapeutics
Status:
Active
Total Funding:
87.49 K USD
Similar Organizations
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
ParkCell
ParkCell is a development of new diagnostics and cell-based therapies for Parkinson’s Disease.
Sophia Bioscience
Sophia Bioscience develops new pharmaceutical treatments for early and metastatic cancers.
Vaxira
Vaxira is a therapeutic vaccine for the treatment of non-small cell lung cancer
Investors List
Georgia Research Alliance
Georgia Research Alliance investment in Grant - Migra Therapeutics
Georgia Research Alliance
Georgia Research Alliance investment in Grant - Migra Therapeutics
More informations about "Migra Therapeutics"
Drug Innovation | Migra Therapeutics
MIGRA Therapeutics is devoted to developing novel platforms for targeted therapy of advanced and drug resistant solid tumor cancers using our stroma-penetrating drug delivery system for …See details»
Migra Therapeutics - Crunchbase Company Profile & Funding
Migra Therapeutics is developing nanotechnology therapies for cancer. Some types of cancer, particularly pancreatic cancer and breast cancer, are comprised of dense barrier cells called …See details»
Team - MIGRA Therapeutics
Yang has expertise in tumor biology, targeted cancer therapy, animal tumor models, and the development of multifunctional nanoparticles for targeted and image-guided therapy. Dr. Lei …See details»
Migra Therapeutics - Funding, Financials, Valuation & Investors
Migra Therapeutics is developing nanotechnology therapies for cancer.See details»
Research - MIGRA Therapeutics
Current research and developmental goal of MIGRA-Therapeutics, LLC, include conducting preclinical development and validation of targeted drug delivery platforms and corresponding therapeutic agents for targeted therapy of …See details»
Georgia Research Alliance - GRA
Led by researchers at Emory University, Migra Therapeutics is developing next-generation nanotechnology therapies for cancer. Some types of cancer, particularly pancreatic cancer …See details»
Migra Therapeutics - Updates, News, Events, Signals & Triggers
Migra Therapeutics is developing nanotechnology therapies for cancer.See details»
Migra Therapeutics: Drug pipelines, Patents, Clinical trials - Synapse
Jul 1, 2023 · Explore Migra Therapeutics with its drug pipeline, therapeutic area, technology platform, .See details»
Migra Therapeutics - SPEEDA Edge
The company focuses on developing novel platforms for targeted therapy of advanced and drug-resistant solid tumor cancers. Migra Therapeutics' core technology revolves around a stroma …See details»
MIGRA-THERAPEUTICS LLC - VentureRadar
MIGRA-THERAPEUTICS LLC VentureRadar profile. Find out more about MIGRA-THERAPEUTICS LLC including the VentureRadar Innovation and Growth scores, Similar …See details»
MIGRA-Therapeutics, LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for MIGRA-Therapeutics, LLC of Atlanta, GA. Get the latest business insights from Dun & Bradstreet.See details»
Award - SBIR
We have developed a receptor targeted and stroma breaking drug delivery platform with novel designs to overcome tumor stromal cellular and extracellular matrix barriers. We have …See details»
Migra Therapeutics - Crunchbase
Migra Therapeutics is developing nanotechnology therapies for cancer.See details»
New funding - MIGRA Therapeutics
We received new $1.8 M NIH/SBIR Phase II grant on high efficent drug delivery system development.See details»
MIGRA-Therapeutics, LLC - VentureRadar
Dec 26, 2020 · Find out more about MIGRA-Therapeutics, LLC including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»
Goals - MIGRA Therapeutics
Challenges in cancer therapy. pancreatic cancer prognosesSee details»
Migra Therapeutics - Tech Stack, Apps, Patents & Trademarks
Migra Therapeutics is developing nanotechnology therapies for cancer.See details»
Current Residents | Emory School of Medicine
The companies that are moving to Lab2Launch are pushing the boundary of science and span a broad spectrum of biomedical innovation areas, including therapeutics, vaccine development …See details»
News - MIGRA Therapeutics
Top of page. MIGRA-Therapeutics. LLC. HomeSee details»
Publications - MIGRA Therapeutics
Make sure you list the precise publishing medium of your work, whether it be a book, an essay, an article, or a research manuscript. If your work appears only on certain pages, include those …See details»